Compare PMT & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PMT | IRMD |
|---|---|---|
| Founded | 2009 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2014 |
| Metric | PMT | IRMD |
|---|---|---|
| Price | $12.06 | $93.74 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 77.9K |
| Earning Date | 04-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 13.39% | 0.86% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $83,814,000.00 |
| Revenue This Year | N/A | $11.99 |
| Revenue Next Year | $2.47 | $9.91 |
| P/E Ratio | ★ $12.59 | $53.42 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $11.15 | $50.00 |
| 52 Week High | $13.80 | $107.90 |
| Indicator | PMT | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.13 | 38.95 |
| Support Level | $11.76 | $92.51 |
| Resistance Level | $12.86 | $105.87 |
| Average True Range (ATR) | 0.21 | 3.02 |
| MACD | 0.08 | -0.40 |
| Stochastic Oscillator | 96.79 | 17.66 |
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.